Showing results (1691-1700 of 1,970) with videos related to

Sort By:
Pageof 197
International Journal of Toxicology|February 22, 2015
Preclinical studies on the pharmacokinetics, safety, and toxicology of oxfendazole: toward first in human studiesEllen E Codd, Hanna H Ng, Claire McFarlane, et al.
Orphanet Journal of Rare Diseases|August 13, 2024
A standard set of outcome measures for the comprehensive assessment of oral health and occlusion in individuals with osteogenesis imperfectaL Blokland, H Arponen, A Ahmad, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 12, 2015
ADAM12: a genetic modifier of preclinical peripheral arterial diseaseAyotunde O Dokun, Lingdan Chen, Mitsuharu Okutsu, et al.
Kidney International|May 9, 2018
Factors leading to the discard of deceased donor kidneys in the United StatesSumit Mohan, Mariana C Chiles, Rachel E Patzer, et al.
The Journal of Urology|December 22, 2009
The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinomaTsz-Fung F Chow, Marina Mankaruos, Andreas Scorilas, et al.
Frontiers in Physiology|April 17, 2023
Altered coronary artery function, arteriogenesis and endothelial YAP signaling in postnatal hypertrophic cardiomyopathyPaulina Langa, Richard J Marszalek, Chad M Warren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
Adjuvant immunotherapy of patients with high-risk melanoma using vaccinia viral lysates of melanoma: results of a randomized trialPeter Hersey, Alan S Coates, William H McCarthy, et al.
Circulation Research|May 4, 2002
Expression of slow skeletal troponin I in hearts of phospholamban knockout mice alters the relaxant effect of beta-adrenergic stimulationBeata M Wolska, Grace M Arteaga, James R Peña, et al.
The American Journal of Cardiology|March 28, 2006
Frequency of recurrent ST-elevation myocardial infarction after fibrinolytic therapy in a different territory as a manifestation of multiple unstable coronary arterial plaquesJohn J Edmond, John K French, Ralph A H Stewart, et al.
The Medical Journal of Australia|October 17, 2002
Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: is it cost-effective?Paul P Glasziou, Simon D Eckermann, Sarah E Mulray, et al.
Pageof 197